Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Urban One Class D
UONEK
$18.6M
| $200K | ﹤0.01% |
43,390
-1,809
| -4% | -$9.03K |
|
3077
Sable Offshore Corp
SOC
$925M
| $199K | ﹤0.01% |
+64,540
| New | +$822K |
|
3078
ReposiTrak
TRAK
$145M
| $198K | ﹤0.01% |
21,991
-878
| -4% | -$8.02K |
|
3079
Senseonics Holdings Inc
SENS
$461M
| $197K | ﹤0.01% |
34,637
+6,986
| +25% | +$44.8K |
|
|
IAUX
3080
i-80 Gold Corp
IAUX
$1.52B
| $193K | ﹤0.01% |
133,708
-18,614
| -12% | -$28.7K |
|
3081
Research Solutions
RSSS
$71.7M
| $191K | ﹤0.01% |
82,442
+4,480
| +6% | +$10.6K |
|
3082
Avalon Holdings
AWX
$10.4M
| $189K | ﹤0.01% |
75,897
| – | – |
|
3083
Prelude Therapeutics
PRLD
$366M
| $187K | ﹤0.01% |
35,210
| – | – |
|
3084
Tonix Pharmaceuticals
TNXP
$204M
| $185K | ﹤0.01% |
+14,521
| New | +$187K |
|
3085
Rallybio
RLYB
$89.6M
| $180K | ﹤0.01% |
11,280
| – | – |
|
3086
Rapid Micro Biosystems
RPID
$61.7M
| $180K | ﹤0.01% |
104,192
+16,603
| +19% | +$35K |
|
3087
Cohen & Co
COHN
$34.9M
| $175K | ﹤0.01% |
12,873
+2,608
| +25% | +$39.2K |
|
|
DGXX
3088
Digi Power X Inc
DGXX
$386M
| $173K | ﹤0.01% |
31,660
-108,421
| -77% | -$591K |
|
3089
Gevo
GEVO
$388M
| $172K | ﹤0.01% |
114,805
-24,050
| -17% | -$42.4K |
|
3090
HF Foods Group
HFFG
$92.3M
| $172K | ﹤0.01% |
121,498
-10,870
| -8% | -$21K |
|
|
FDSB
3091
Fifth District Bancorp
FDSB
$97M
| $169K | ﹤0.01% |
+10,432
| New | +$159K |
|
|
OGI
3092
Organigram Holdings
OGI
$151M
| $167K | ﹤0.01% |
164,139
-9,745
| -6% | -$11.9K |
|
3093
Nortech Systems
NSYS
$31.9M
| $167K | ﹤0.01% |
+10,624
| New | +$155K |
|
3094
Gyre Therapeutics
GYRE
$714M
| $167K | ﹤0.01% |
25,268
| – | – |
|
|
TALK
3095
DELISTED
Talkspace
TALK
| $165K | ﹤0.01% |
31,654
-2,679,987
| -99% | -$13.9M |
|
3096
Savara
SVRA
$1.09B
| $163K | ﹤0.01% |
26,426
+5
| +0% | +$27 |
|
|
ELSE
3097
DELISTED
Electro-Sensors
ELSE
| $162K | ﹤0.01% |
21,141
+506
| +2% | +$3.6K |
|
|
WW
3098
WW International
WW
$148M
| $162K | ﹤0.01% |
+10,112
| New | +$135K |
|
3099
American Shared Hospital Services
AMS
$9.81M
| $161K | ﹤0.01% |
102,140
-102,980
| -50% | -$152K |
|
3100
Creative Realities
CREX
$38.3M
| $160K | ﹤0.01% |
38,766
-16,124
| -29% | -$60.9K |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.